Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/3866
Title: Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
Authors: PONTES-JUNIOR, JoseREIS, Sabrina ThalitaBERNARDES, Felipe S.OLIVEIRA, Luiz C. N.BARROS, Erika Aparecida Felix deDALL'OGLIO, Marcos FranciscoTIMOSCZUK, Luciana M. S.RIBEIRO-FILHO, Leopoldo A.SROUGI, MiguelLEITE, Katia R. M.
Citation: INTERNATIONAL BRAZ J UROL, v.39, n.3, p.335-342, 2013
Abstract: Integrins are transmembrane glycoprotein receptors that regulate cell-matrix interactions, thus functioning as sensors from the environment. They also act as cell adhesion molecules that are responsible for the maintenance of the normal epithelial phenotype. Some studies have reported a correlation between carcinogenesis and changes in integrin expression, especially beta 1 integrin, however its role in prostate cancer (PC) is unclear. The aim of our study was to evaluate the expression of beta 1 integrin in localized PC and to correlate the pattern of expression with recurrence after surgical treatment. Methods For this case-control study, we retrospectively selected surgical specimens from 111 patients with localized PC who underwent radical prostatectomy. Recurrence was defined as a PSA level exceeding 0.2ng/mL after surgery, and the median follow-up was 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two samples from each tumor. We employed a semiquantitative analysis and considered a case as positive when the expression was strong and diffusely present. Results: There was a loss of 11 cases during the tissue micro array assembling. beta 1 expression was positive in 79 of the 100 evaluated cases (79%). The univariate and multivariate analyses showed that the negative expression of beta 1 integrin was associated with biochemical recurrence (p = 0.047) and time to recurrence after radical prostatectomy (p = 0.023). When beta 1 was negative, the odds ratio for recurrence was 2.78 times higher than that observed in the positive cases [OR = 2.78, p = 0.047, IC 95% (1.01-7.66)]. Conclusions: The loss of beta 1 integrin immune expression was correlated with biochemical recurrence in patients treated with radical prostatectomy for localized PC.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCG
Departamento de Cirurgia - FM/MCG

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/55
LIM/55 - Laboratório de Urologia


Files in This Item:
File Description SizeFormat 
art_PONTES-JUNIOR_Correlation_between_Beta1_integrin_expression_and_prognosis_in_2013.PDFpublishedVersion (English)197.44 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.